GHK-Cu Research — Stemcode Peptides

Apply it if you want minimal surface texture improvement, but don't expect measurable width or depth reduction. Mature striae albae have completed the remodeling phase. Fibroblast activity has returned to baseline, and the scar tissue has fully stabilized. The 2015 Leyden trial excluded participants with striae older than two years for this reason. Copper-peptide intervention works by amplifying active remodeling; once that window has closed, the enzymatic pathway GHK-Cu targets is no longer upregulated.

Expect that. Hair growth cycles operate on 12–16 week timelines. Follicles must transition from telogen (resting) to anagen (growth), and then the new hair shaft must grow long enough to be visible above the scalp surface. GHK-Cu studied androgenetic alopecia research consistently shows the first measurable density increases appear at week 8–10, with peak improvements at 16–20 weeks. Early dropout is the most common reason patients report "GHK-Cu didn't work". The mechanism is regenerative, not instantaneous like minoxidil's vasodilation effect.

Administer GHK-Cu only within physiological copper tolerance ranges. Research models use 1–10 micromolar concentrations, well below the 50+ micromolar threshold where free copper begins to generate oxidative stress through Fenton reactions. The peptide structure chelates copper tightly, preventing it from participating in redox cycling that generates hydroxyl radicals. Individuals with Wilson's disease (impaired copper excretion) or documented copper overload should avoid exogenous copper-containing compounds entirely, but normal physiological copper status does not contraindicate GHK-Cu at standard research doses. The peptide's binding constant for copper is high enough (log K = 16.4) that it does not release free copper under normal tissue pH and redox conditions.

Avoid applying GHK-Cu and L-ascorbic acid (vitamin C) in the same routine. Ascorbic acid's low pH (2.5–3.5) disrupts copper coordination and reduces GHK-Cu bioavailability by approximately 60%. Use vitamin C in morning application and GHK-Cu at night, or separate applications by at least 8 hours. Retinoids (tretinoin, adapalene) can be combined with GHK-Cu. In fact, a 2019 study published in the Journal of Cosmetic Dermatology found that GHK-Cu applied 30 minutes after tretinoin reduced retinoid-induced irritation by 40% while maintaining the collagen-stimulating effects of both compounds. The mechanism: GHK-Cu's anti-inflammatory effects (mediated by reduced IL-6 and TNF-α secretion) counteract the transient inflammation tretinoin causes during the retinization period. Apply tretinoin first, wait 20–30 minutes for penetration, then apply GHK-Cu as a second layer.

No pharmacokinetic interactions have been documented between topical GHK-Cu and minoxidil or oral finasteride. The mechanisms are complementary: finasteride reduces DHT-driven follicular miniaturization, minoxidil extends anagen phase via potassium channel opening, and GHK-Cu reduces perifollicular inflammation while promoting dermal papilla health. Combination protocols in unpublished observational studies suggest additive benefits, particularly in cases where inflammation is a significant component of AGA progression.